6.
Khan T, Sankhe K, Suvarna V, Sherje A, Patel K, Dravyakar B
. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents. Biomed Pharmacother. 2018; 103:923-938.
DOI: 10.1016/j.biopha.2018.04.021.
View
7.
DeLano W, Ultsch M, de Vos A, Wells J
. Convergent solutions to binding at a protein-protein interface. Science. 2000; 287(5456):1279-83.
DOI: 10.1126/science.287.5456.1279.
View
8.
Levine C, Hiasa H, Marians K
. DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochim Biophys Acta. 1998; 1400(1-3):29-43.
DOI: 10.1016/s0167-4781(98)00126-2.
View
9.
Samra Z, Rosenberg S, Dan M
. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. J Chemother. 2011; 23(2):77-9.
DOI: 10.1179/joc.2011.23.2.77.
View
10.
Man R, Zhang X, Yang Y, Jiang A, Zhu H
. Recent Progress in Small Molecular Inhibitors of DNA Gyrase. Curr Med Chem. 2021; 28(28):5808-5830.
DOI: 10.2174/1871529X21666210202113128.
View
11.
Edwards M, Flatman R, Mitchenall L, Stevenson C, Le T, Clarke T
. A crystal structure of the bifunctional antibiotic simocyclinone D8, bound to DNA gyrase. Science. 2009; 326(5958):1415-8.
DOI: 10.1126/science.1179123.
View
12.
Zheng N, Li N, Lei L, Zhu B, Qiao K, Wang Q
. An In Vitro and In Vivo Study of Thyroid Disruption of 1,2-Bis(2,4,6-tribromophenoxy)ethane (BTBPE)-A Novel Brominated Flame Retardant. Environ Health (Wash). 2024; 2(1):42-51.
PMC: 11504562.
DOI: 10.1021/envhealth.3c00140.
View
13.
Dighe S, Collet T
. Recent advances in DNA gyrase-targeted antimicrobial agents. Eur J Med Chem. 2020; 199:112326.
DOI: 10.1016/j.ejmech.2020.112326.
View
14.
Guo R, Qi Y, Li B, Tian J, Wang Z, Qu R
. Efficient degradation of alkyl imidazole ionic liquids in simulated sunlight irradiated periodate system: Kinetics, reaction mechanisms, and toxicity evolution. Water Res. 2022; 226:119316.
DOI: 10.1016/j.watres.2022.119316.
View
15.
Nakatani M, Mizunaga S, Takahata M, Nomura N
. Inhibitory activity of garenoxacin against DNA gyrase of Mycoplasma pneumoniae. J Antimicrob Chemother. 2012; 67(8):1850-2.
DOI: 10.1093/jac/dks140.
View
16.
Zhang R, Zhang G, Zheng Q, Tang J, Chen Y, Xu W
. Occurrence and risks of antibiotics in the Laizhou Bay, China: impacts of river discharge. Ecotoxicol Environ Saf. 2012; 80:208-15.
DOI: 10.1016/j.ecoenv.2012.03.002.
View
17.
Kumar M, Sridharan S, Sawarkar A, Shakeel A, Anerao P, Mannina G
. Current research trends on emerging contaminants pharmaceutical and personal care products (PPCPs): A comprehensive review. Sci Total Environ. 2022; 859(Pt 1):160031.
DOI: 10.1016/j.scitotenv.2022.160031.
View
18.
Wang X, Yang C, Sun Y, Sui X, Zhu T, Wang Q
. A novel screening strategy of anti-SARS-CoV-2 drugs via blocking interaction between Spike RBD and ACE2. Environ Int. 2021; 147:106361.
PMC: 7832953.
DOI: 10.1016/j.envint.2020.106361.
View
19.
Chang X, Meyer M, Liu X, Zhao Q, Chen H, Chen J
. Determination of antibiotics in sewage from hospitals, nursery and slaughter house, wastewater treatment plant and source water in Chongqing region of Three Gorge Reservoir in China. Environ Pollut. 2010; 158(5):1444-50.
DOI: 10.1016/j.envpol.2009.12.034.
View
20.
Bartoskova M, Dobsikova R, Stancova V, Pana O, Zivna D, Plhalova L
. Norfloxacin--toxicity for Zebrafish (Danio rerio) focused on oxidative stress parameters. Biomed Res Int. 2014; 2014:560235.
PMC: 3972947.
DOI: 10.1155/2014/560235.
View